<!DOCTYPE html>
<html lang="en" dir="ltr">
    <head>
        <meta charset="utf-8">
        <link rel="stylesheet" href="/static/rendered_html/uslm.css">
        <link rel="stylesheet" href="/static/rendered_html/style.css">
        <script src="https://kit.fontawesome.com/2ce1080035.js" crossorigin="anonymous"></script>
        <script lang="text/javascript" src="/static/rendered_html/omni.js" defer></script>

        <!-- Table of Contents button section sheet. Would ideally be a working breadcrumb --> 
        <img src="../omni.jpg" alt="Omnibuster" style="width:100%">
        <ul class="breadcrumb" style="text-align:center">
            <!-- TODO GENERALIZE THIS --> 
            <li><a href="index.html"> Table of Contents</a></li>
            
                <li> Title II </a></li>
            
                <li> Subtitle D </a></li>
            
                <li> Section 2301 </a></li>
            
        </ul>


        <!-- <title> Omnibuster </title>
 -->
    </head>

    <body>
        <br><br><br>
        <div class="section">
            <div class="buttons">
                <div class="navbar">
                    <div>
                        <button onclick="highlightSelection();">Highlight Text</button>
                    </div>
                    <div>
                        <button onclick="annotateSelection();">[Not working] Annotate Text</button>
                    </div> 
                </div>
            </div>
            <p> 
                <section id="d2034e5668" identifier="/us/bill/117/hr/1319/tII/stD/s2301" style="-uslm-lc:I650144">
<num value="2301">SEC. 2301. </num>
<heading>FUNDING FOR COVID–19 VACCINE ACTIVITIES AT THE CENTERS FOR DISEASE CONTROL AND PREVENTION.</heading>
<subsection class="indent0 fontsize10" id="d2034e5673" identifier="/us/bill/117/hr/1319/tII/stD/s2301/a" style="-uslm-lc:I650120">
<num style="-uslm-lc:emspace2" value="a">(a) </num>
<heading>
<inline class="small-caps">In General</inline>.—
                        </heading>
<content>In addition to amounts otherwise available, there is appropriated to the Secretary of Health and Human Services (in this subtitle referred to as the “Secretary”) for fiscal year 2021, out of any money in the Treasury not otherwise appropriated, $7,500,000,000, to remain available until expended, to carry out activities to plan, prepare for, promote, distribute, administer, monitor, and track COVID–19 vaccines.</content>
</subsection>
<subsection class="indent0 fontsize10" id="d2034e5684" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b" style="-uslm-lc:I650120">
<num style="-uslm-lc:emspace2" value="b">(b) </num>
<heading>
<inline class="small-caps">Use of Funds</inline>.—
                        </heading>
<chapeau>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, and in consultation with other agencies, as applicable, shall, in conducting activities referred to in subsection (a)—</chapeau>
<paragraph class="indent1 fontsize10" id="d2034e5693" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/1" style="-uslm-lc:I650122">
<num style="-uslm-lc:emspace2" value="1">(1) </num>
<content>conduct activities to enhance, expand, and improve nationwide COVID–19 vaccine distribution and administration, including activities related to distribution of ancillary medical products and supplies related to vaccines; and</content>
</paragraph>
<paragraph class="indent1 fontsize10" id="d2034e5700" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2" style="-uslm-lc:I650122">
<num style="-uslm-lc:emspace2" value="2">(2) </num>
<chapeau>provide technical assistance, guidance, and support to, and award grants or cooperative agreements to, State, local, Tribal, and territorial public health departments for enhancement of COVID–19 vaccine distribution and administration capabilities, including—</chapeau>
<subparagraph class="indent2 fontsize10" id="d2034e5705" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2/A" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="A">(A) </num>
<content>the distribution and administration of vaccines licensed under section 351 of the Public Health Service Act (
                                    <a href="https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section262&amp;num=0&amp;edition=prelim" target="_blank"><ref href="/us/usc/t42/s262">42 U.S.C. 262</ref></a>) or authorized under section 564 of the Federal Food, Drug, and Cosmetic Act (
                                    <a href="https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360bbb–3&amp;num=0&amp;edition=prelim" target="_blank"><ref href="/us/usc/t21/s360bbb–3">21 U.S.C. 360bbb–3</ref></a>) and ancillary medical products and supplies related to vaccines;
                                </content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5718" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2/B" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="B">(B) </num>
<content>the establishment and expansion, including staffing support, of community vaccination centers, particularly in underserved areas;</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5725" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2/C" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="C">(C) </num>
<content>the deployment of mobile vaccination units, particularly in underserved areas;</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5732" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2/D" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="D">(D) </num>
<content>information technology, standards-based data, and reporting enhancements, including improvements necessary to support standards-based sharing of data related to vaccine distribution and vaccinations and systems that enhance vaccine safety, effectiveness, and uptake, particularly among underserved populations;</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5739" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2/E" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="E">(E) </num>
<content>facilities enhancements;</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5747" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2/F" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="F">(F) </num>
<content>communication with the public regarding when, where, and how to receive COVID–19 vaccines; and</content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5754" identifier="/us/bill/117/hr/1319/tII/stD/s2301/b/2/G" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="G">(G) </num>
<content>transportation of individuals to facilitate vaccinations, including at community vaccination centers and mobile vaccination units, particularly for underserved populations.</content>
</subparagraph>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" id="d2034e5763" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c" style="-uslm-lc:I650120">
<num style="-uslm-lc:emspace2" value="c">(c) </num>
<heading>
<inline class="small-caps">Supplemental Funding for State Vaccination Grants</inline>.—
                        </heading>
<paragraph class="indent1 fontsize10" id="d2034e5770" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/1" style="-uslm-lc:I650122">
<num style="-uslm-lc:emspace2" value="1">(1) </num>
<heading>
<inline class="small-caps">Definitions</inline>.—
                            </heading>
<chapeau>In this subsection:</chapeau>
<subparagraph class="indent2 fontsize10" id="d2034e5779" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/1/A" role="definitions" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="A">(A) </num>
<heading>
<inline class="small-caps">Base formula</inline>.—
                                </heading>
<content>The term “
                                    <term>base formula</term>” means the allocation formula that applied to the Public Health Emergency Preparedness cooperative agreement in fiscal year 2020.
                                </content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5790" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/1/B" role="definitions" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="B">(B) </num>
<heading>
<inline class="small-caps">Alternative allocation</inline>.—
                                </heading>
<content>The term “
                                    <term>alternative allocation</term>” means an allocation to each State, territory, or locality calculated using the percentage derived from the allocation received by such State, territory, or locality of the aggregate amount of fiscal year 2020 Public Health Emergency Preparedness cooperative agreement awards under section 319C–1 of the Public Health Service Act (
                                    <a href="https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section247d–3a&amp;num=0&amp;edition=prelim" target="_blank"><ref href="/us/usc/t42/s247d–3a">42 U.S.C. 247d–3a</ref></a>).
                                </content>
</subparagraph>
</paragraph>
<paragraph class="indent1 fontsize10" id="d2034e5805" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/2" style="-uslm-lc:I650122">
<num style="-uslm-lc:emspace2" value="2">(2) </num>
<heading>
<inline class="small-caps">Supplemental funding</inline>.—
                            </heading>
<subparagraph class="indent2 fontsize10" id="d2034e5812" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/2/A" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="A">(A) </num>
<heading>
<inline class="small-caps">In general</inline>.—
                                </heading>
<content>Not later than 21 days after the date of enactment of this Act, the Secretary shall, out of amounts described in subsection (a), provide supplemental funding to any State, locality, or territory that received less of the amounts that were appropriated under 
                                    <ref href="/us/pl/116/260/dM/tIII">title III of division M of Public Law 116–260</ref> for vaccination grants to be issued by the Centers for Disease Control and Prevention than such State, locality, or territory would have received had such amounts been allocated using the alternative allocation.
                                </content>
</subparagraph>
<subparagraph class="indent2 fontsize10" id="d2034e5826" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/2/B" style="-uslm-lc:I650124">
<num style="-uslm-lc:emspace2" value="B">(B) </num>
<heading>
<inline class="small-caps">Amount</inline>.—
                                </heading>
<chapeau>The amount of supplemental funding provided under this subsection shall be equal to the difference between—</chapeau>
<clause class="indent3 fontsize10" id="d2034e5835" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/2/B/i" style="-uslm-lc:I650126">
<num style="-uslm-lc:emspace2" value="i">(i) </num>
<content>the amount the State, locality, or territory received, or would receive, under the base formula; and</content>
</clause>
<clause class="indent3 fontsize10" id="d2034e5842" identifier="/us/bill/117/hr/1319/tII/stD/s2301/c/2/B/ii" style="-uslm-lc:I650126">
<num style="-uslm-lc:emspace2" value="ii">(ii) </num>
<content>the amount the State, locality, or territory would receive under the alternative allocation.</content>
</clause>
</subparagraph>
</paragraph>
</subsection>
</section>
            </p>
        </div>  

        <!-- previous section -->
        <button onclick="location.href='section_s2206.html'" id="ls-btn-prev-sec" title="go to previous section">
            <i class="fas fa-angle-left"></i>
        </button>
        <!-- end previous section -->

        <!-- next section -->
        <button onclick="location.href='section_s2302.html'" id="ls-btn-next-sec" title="go to next section" data-ls-target-index="2">
            <i class="fas fa-angle-right"></i>
        </button>
        <!-- end next section -->

    </body>
